Categories: All postsAnalysts

Pollard Banknote has significant upside, Echelon Wealth says

Lottery ticket company Pollard Banknote Limited (Pollard Banknote Stock Quote, Chart, News: TSX:PBL) is benefiting from co-opetition with its two top rivals, says analyst Ralph Garcea of Echelon Wealth Partners, who maintains both his “Buy” recommendation for PBL and one-year price target of $24.00.

Winnipeg-based Pollard Banknote’s cooperative competition with competitors IGT and Scientific Games is significant, says Garcea in a note to clients on Tuesday.

“IGT, a key PBL competitor, announced it has been awarded a 10-year contract, effective May 13, 2018, with the South Carolina Education Lottery (SCEL) to provide an array of lottery technology and ongoing services,” said the analyst. “This is a great illustration of the co-opetition between the industry’s top three players within a given customer, each with a different value proposition.”

Garcea notes that Pollard completed in 2017 the $25 million installation of a new in-line printing press in Ypsilanti, Michigan, which will expand the company’s printing capacity by 35 per cent and give it operating leverage through favourable overhead absorption.

The analyst says that Pollard’s diversified revenue and growing customer base give the company a good buffer — a “revenue moat.” “Pollard’s revenue is derived from long-term contracts (typically 3 to 5 years) with renewal extensions of several years,” says the analyst. “Pollard has built a sound reputation with over 50 customers across the globe including the Americas, Europe, and Asia.”

Garcea maintains his estimates for PBL, projecting a total revenue of $337.2 million in 2018 with an adjusted EBITDA of $55.8 million.

Garcea says PBL is currently trading at a 2018E EV/Sales, EV/EBITDA, and P/E of 1.7x, 10.4x, and 23.6x, respectively, versus its global gaming comparables average of 3.1x, 10.4x, and 17.8x, respectively.

The analyst maintains his “Buy” rating and one-year target price of $24.00, representing a 17 per cent projected return at the time of publication.

Tagged with: pbl
Jayson MacLean

Jayson is a writer, researcher and educator with a PhD in political philosophy from the University of Ottawa. His interests range from bioethics and innovations in the health sciences to governance, social justice and the history of ideas.

Recent Posts

Aurora Cannabis shareholders should take the Organigram deal, analyst says

TD Cowen analyst Derek Lessard recommends Aurora Cannabis shareholders accept Organigram Global’s (Organigram Global Stock Quote, Chart, News, Analysts, Financials… [Read More]

3 hours ago

Here’s what differentiates Telesat from Starlink: analyst

Desjardins Securities analyst Jerome Dubreuil initiated coverage of Telesat (Telesat Stock Quote, Chart, News, Analysts, Financials TSX:TSAT) with a “Buy”… [Read More]

4 hours ago

Shopify’s dominance is far from over, this analyst says

National Bank Financial analyst Doug Taylor raised his target on Shopify (Shopify Stock Quote, Chart, News, Analysts, Financials NYSE:SHOP) to… [Read More]

5 hours ago

This is my top U.S. cannabis stock, analyst says

Green Thumb Industries (Green Thumb Industries Stock Quote, Chart, News, Analysts, Financials CSE:GTII) reported stronger-than-expected third-quarter revenue and profitability, supported… [Read More]

5 hours ago

Should you sell your Playtika stock?

Playtika Holding Corporation (Playtika Holding Corp Stock Quote, Chart, News, Analysts, Financials NASDAQ:PLTK) reported stronger-than-expected third-quarter profitability and ended its… [Read More]

6 hours ago

TD raises price target on Lumine Group to $45.00

Lumine Group’s (Lumine Group Stock Quote, Chart, News, Analysts, Financials TSXV:LMN) third-quarter revenue increased 55% as acquisitions contributed to accelerating… [Read More]

7 hours ago